Literature DB >> 9566664

The epidemiology of hyperuricaemia and gout in Taiwan aborigines.

C T Chou1, J S Lai.   

Abstract

To determine the prevalence of hyperuricaemia, gout and gout-related factors in Central Taiwan Atayal aborigines, 342 subjects over 18 yr old were interviewed and examined. A questionnaire was designed to screen for signs and symptoms of gout and gout-related risk factors. Serum uric acid, triglyceride and creatinine were measured in all subjects. The prevalence of hyperuricaemia was 41.4% and that of gout 11.7% in aborigines. The uric acid level was 7.9+/-1.7 mg/dl in males and 5.7+/-1.5 in females, and differed significantly under age 70 yr (P < 0.001). Significantly increased triglyceride, creatinine and alcoholism was found in gouty patients compared with non-gouty patients. In 40 cases with gout, 54% had tophi and 35% of their first-degree relatives had gout. The high prevalence of hyperuricaemia and gout in Taiwan Atayal aborigines, a significant family predisposition, increased creatinine level and alcoholism suggest multiple factors affecting the hyperuricaemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566664     DOI: 10.1093/rheumatology/37.3.258

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  25 in total

Review 1.  Rheumatic disease and the Australian aborigine.

Authors:  R A Roberts-Thomson; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

Review 2.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 3.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 4.  Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.

Authors:  José M A Wijnands; Wolfgang Viechtbauer; Kristof Thevissen; Ilja C W Arts; Pieter C Dagnelie; Coen D A Stehouwer; Sjef van der Linden; Annelies Boonen
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

Review 5.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

6.  Coexisting ankylosing spondylitis and gouty arthritis.

Authors:  Huei-Huang Ho; Kuang-Hui Yu; Ji-Yih Chen; Ja-Liang Lin; Yeong-Jian Jan Wu; Shue-Fen Luo; Lieh-Bang Liou
Journal:  Clin Rheumatol       Date:  2007-03-14       Impact factor: 2.980

7.  Gout in the Hmong in the United States.

Authors:  Salman Wahedduddin; Jasvinder A Singh; Kathleen A Culhane-Pera; Elie Gertner
Journal:  J Clin Rheumatol       Date:  2010-09       Impact factor: 3.517

8.  Reference range of serum uric acid and prevalence of hyperuricemia: a cross-sectional study from baseline data of ELSA-Brasil cohort.

Authors:  Murillo Dório; Isabela M Benseñor; Paulo Lotufo; Itamar S Santos; Ricardo Fuller
Journal:  Adv Rheumatol       Date:  2022-05-08

Review 9.  Prevalence of rheumatic diseases and disability in China.

Authors:  Yao-Jun Xiang; Sheng-Ming Dai
Journal:  Rheumatol Int       Date:  2008-12-06       Impact factor: 2.631

10.  Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.

Authors:  Ji-Won Kim; Sang Gyu Kwak; Hwajeong Lee; Seong-Kyu Kim; Jung-Yoon Choe; Sung-Hoon Park
Journal:  Rheumatol Int       Date:  2017-07-04       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.